Yangwa:GroupIntro: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
<html> | <html> | ||
<!-- 顶部标题 --> | |||
<h1 style="text-align: center; font-size: 36px; margin-top: 20px; margin-bottom: 10px; color: #000;"> | |||
Synthetic BioPharmaceutics Group | |||
</h1> | |||
<p style="text-align: center; font-size: 18px; margin-bottom: 30px; color: #444;"> | |||
（合成生物药剂学课题组） | |||
</p> | |||
<style> | <style> | ||
body { | body { | ||
| Line 10: | Line 19: | ||
margin-top: 40px; | margin-top: 40px; | ||
font-size: 28px; | font-size: 28px; | ||
color: #000000; | color: #000000; | ||
} | } | ||
| Line 92: | Line 94: | ||
</style> | </style> | ||
<h2>Research Focus</h2> | <!-- 🔬 Research --> | ||
<h2 id="research">🔬 Research Focus</h2> | |||
<details open> | <details open> | ||
| Line 109: | Line 112: | ||
</details> | </details> | ||
<h2>Current Members</h2> | <!-- 👤 Members --> | ||
<h2 id="members">👤 Current Members</h2> | |||
<div class="card-grid"> | <div class="card-grid"> | ||
| Line 139: | Line 143: | ||
</div> | </div> | ||
<h2>Publications</h2> | <!-- 📚 Publications --> | ||
<h2 id="publications">📚 Publications</h2> | |||
<ul> | <ul> | ||
| Line 146: | Line 151: | ||
</ul> | </ul> | ||
<h2>Contact</h2> | <!-- 📞 Contact --> | ||
<h2 id="contact">📞 Contact</h2> | |||
<p>📍 West China School of Pharmacy, Sichuan University</p> | <p>📍 West China School of Pharmacy, Sichuan University</p> | ||
<p>📧 yangwa@lab.edu</p> | <p>📧 yangwa@lab.edu</p> | ||
<p>🌐 <a href="http://yangwalab.com" target="_blank">yangwalab.com</a></p> | <p>🌐 <a href="http://yangwalab.com" target="_blank">yangwalab.com</a></p> | ||
</html> | </html> | ||
Revision as of 03:34, 12 April 2025
Synthetic BioPharmaceutics Group
（合成生物药剂学课题组）
🔬 Research Focus
DNA/RNA Origami for Therapy
Design of 2D and 3D DNA/RNA nanostructures to deliver siRNA, aptamers, and proteins with precise spatial control and responsiveness to tumor cues.Logic-Gated Immune Activation
We engineer aptamer–antibody logic systems and RNA circuits that enable conditional T cell activation within immunosuppressive tumor environments.Peptide–DNA Conjugates for Receptor Clustering
We create pH-responsive peptide–DNA materials that self-assemble in acidic tumor microenvironments to cluster death receptors (e.g., TRAIL-R) and induce apoptosis.👤 Current Members
Yang Wang
PI
Xie Guangneng
PhD Student
Xu Anran
PhD Student
Zhang Wei
Master Student
Li Jie
Intern
📚 Publications
- Wang Y, et al. Programmable DNA robot for cancer therapy. Nature Nanotechnology, 2024.
- Wang Y, et al. RNA origami logic gates for T cell activation. Nature Biomedical Engineering, 2023.
📞 Contact
📍 West China School of Pharmacy, Sichuan University
📧 yangwa@lab.edu